Translational Genomics Research Institute
Award Date: 2022
Duration: 18 months
Program Area: Bioscience
Support for a project to develop and commercialize a blood-based assay for disease monitoring in patients with pancreatic cancer. This grant is awarded under the Flinn Foundation Translational Research Seed Grant Initiative to support research collaborations between basic scientists and clinical researchers.